Skip to main content
Veterinary Medicines

Buprelab 0.3 mg/ml solution for injection for dogs and cats

Authorised
  • Buprenorphine hydrochloride

Product identification

Medicine name:
Buprelab 0.3 mg/ml solution for injection for dogs and cats
Active substance:
  • Buprenorphine hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Buprenorphine hydrochloride
    0.32
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
  • Intramuscular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN02AE01
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Box with 1 vial of 10 ml
  • Box with 5 vials of 10 ml
  • Box with 10 vials of 10 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Ministere De La Sante Division De La Pharmacie Et Des Medicaments
Authorisation number:
  • V/006/08/01/2024
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0430/001
Concerned member states:
  • Belgium
  • Cyprus
  • Estonia
  • Finland
  • France
  • Hungary
  • Latvia
  • Lithuania
  • Luxembourg
  • Romania
  • Sweden

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 19/02/2024

Summary of Product Characteristics

English (PDF)
Published on: 27/06/2024
Download

eu-PUAR-esv0430001-mrp-buprelab-0-3-mg-ml-solution-for-injection-for-dogs-and-cats-en.pdf

English (PDF)
Published on: 27/06/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."